Tenaya Announces FDA Clearance of Investigational New Drug Application and Initiation of Phase 1 Safety Study for TN-301 Portfolio News / Karina Tin September 6, 2022 Tenaya Announces FDA Clearance of Investigational New Drug Application and Initiation of Phase 1 Safety Study for TN-301 Read More »
Ribon Therapeutics Announces Late-Breaking Presentation of Preclinical Data on RBN-3143 at the European Respiratory Society International Congress 2022 Portfolio News / Karina Tin September 6, 2022 Ribon Therapeutics Announces Late-Breaking Presentation of Preclinical Data on RBN-3143 at the European Respiratory Society International Congress 2022 Read More »
NGM Bio Presents Updated Preliminary Findings for a Subgroup of Patients with Advanced Prostate Cancer from the Ongoing Phase 1a Dose Escalation Trial of NGM120 in Patients with Advanced Solid Tumors at the ESMO Annual Congress Portfolio News / Karina Tin September 6, 2022 NGM Bio Presents Updated Preliminary Findings for a Subgroup of Patients with Advanced Prostate Cancer from the Ongoing Phase 1a Dose Escalation Trial of NGM120 in Patients with Advanced Solid Tumors at the ESMO Annual Congress Read More »
Revolution Medicines Strengthens Senior Management Team with Promotions and a New Hire Portfolio News / Karina Tin September 1, 2022 Revolution Medicines Strengthens Senior Management Team with Promotions and a New Hire Read More »